• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Atherotech

Anonymous board for Atherotech
Replies
1
Views
824
anonymous
Replies
105
Views
40K
Boogeyman
Replies
7
Views
5K
anonymous
Replies
1
Views
2K
anonymous
Replies
0
Views
2K
anonymous
Replies
3
Views
4K
anonymous
Replies
20
Views
7K
anonymous
Replies
2
Views
2K
anonymous
Replies
8
Views
4K
anonymous
Replies
2
Views
2K
anonymous
Replies
2
Views
2K
anonymous
Replies
3
Views
2K
anonymous
Replies
4
Views
2K
anonymous
Replies
5
Views
2K
anonymous
Replies
6
Views
2K
anonymous
Replies
37
Views
9K
anonymous
  • Poll
Replies
37
Views
10K
anonymous